TMO
42
-6
WDC
37
-3
AAPL
40
-6
OMC
50
-16
DOV
65
-4
MAR
63
-5
TXT
53
-3
AA
56
15
JNPR
50
-6
INTC
41
4
DE
42
3
SO
57
6
TROW
47
-6
BMY
55
-8
DIS
85
3
BEN
50
9
LRCX
37
-9
EQT
51
-3
JNJ
41
3
PYPL
52
-2
TMO
42
-6
WDC
37
-3
AAPL
40
-6
OMC
50
-16
DOV
65
-4
MAR
63
-5
TXT
53
-3
AA
56
15
JNPR
50
-6
INTC
41
4
DE
42
3
SO
57
6
TROW
47
-6
BMY
55
-8
DIS
85
3
BEN
50
9
LRCX
37
-9
EQT
51
-3
JNJ
41
3
PYPL
52
-2
Financhill
Back

Enlivex Therapeutics Vs. Repligen Industry Stock Comparison

Sell
17

ENLV
Enlivex Therapeutics

Last Price:
1.06
Seasonality Move:
14.56%
Sell
30

RGEN
Repligen

Last Price:
124.90
Seasonality Move:
7.3%
Sell
17
Enlivex Therapeutics (ENLV) is a Sell

Is Enlivex Therapeutics a Buy, Sell or Hold?

  • The current Enlivex Therapeutics [ENLV] share price is $1.07. The Score for ENLV is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • ENLV is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ENLV Stock Price Chart

What is Enlivex Therapeutics's stock price today?

  • The Enlivex Therapeutics share price today is $1.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENLV is experiencing slight buying pressure.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $124.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

ENLV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 23.24 Sell
Chaikin Money Flow: 43470 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.21 - 1.53) Sell
Bollinger Bands (100): (1.25 - 1.51) Sell

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 36.22 Sell
Chaikin Money Flow: -1285419 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (134.94 - 146.38) Sell
Bollinger Bands (100): (130 - 153.64) Sell

ENLV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.18 Sell
20-day SMA: 1.33 Sell
50-day SMA: 1.43 Sell
200-day SMA: 1.9 Sell
8-day EMA: 1.18 Sell
20-day EMA: 1.29 Sell
50-day EMA: 1.37 Sell
200-day EMA: 1.73 Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.02 Sell
20-day SMA: 140.23 Sell
50-day SMA: 141.19 Sell
200-day SMA: 157.58 Sell
8-day EMA: 139.7 Sell
20-day EMA: 140.54 Sell
50-day EMA: 141.71 Sell
200-day EMA: 151.3 Sell

Enlivex Therapeutics Earnings Growth & ENLV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.10 per share.

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

Enlivex Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):